Barclays lowered the firm’s price target on Revance (RVNC) to $3 from $7 and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVNC:
- Unusually active option classes on open December 12th
- Revance receives acquisition offer from Crown Laboratories for $3.10 per share
- Unusually active option classes on open December 10th
- Revance price target lowered to $3.10 from $6.66 at Mizuho
- Omnicom to acquire Interpublic, China to investigate Nvidia: Morning Buzz